Prevena Restor Bellaform
Device Negative Pressure Systems & Dressings
PDI 00849554007130
General payments
$1,246,434
Research payments
$309,256
Through program year 2025, $1,246,434 in general payments and $309,256 in research payments were reported against Prevena Restor Bellaform (Negative Pressure Systems & Dressings).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $292,686 | 204 |
| 2025 | Research | $84,900 | 4 |
| 2024 | General | $210,609 | 261 |
| 2024 | Research | $50,106 | 1 |
| 2023 | General | $419,612 | 435 |
| 2023 | Research | $174,250 | 2 |
| 2022 | General | $323,527 | 431 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 17 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 37 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,331 general · 7 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.